SCHEMBL6205149

SCHEMBL6205149

COC(O)c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 1/20 0.44
▸ AOC3 Q16853 2/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ BRD4 O60885 1/20 0.42
▸ LMNA P02545 3/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ IDO1 P14902 2/20 0.41
▸ TDO2 P48775 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ HIF1A Q16665 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ GAA P10253 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ CYP2A6 P11509 1/20 0.38
▸ HDAC4 P56524 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9979794 0.87 AOC3 (0.34) AOC3TSHRGAA
SCHEMBL13283559 0.83 TYR (0.41) SMN1; SMN2IDO1MAPK1HIF1AGAA
SCHEMBL21769395 0.78 ESR1 (0.50) LMNASMN1; SMN2TSHRHIF1ATDP1
SCHEMBL17124666 0.78 TSHR (0.36) AOC3TSHRKMT2A
SCHEMBL6203868 0.78 CHRNA7 (0.41) LMNATSHRTDP1MEN1KMT2A
SCHEMBL2645634 0.76 BLM (0.32) TSHRGAAKMT2A
SCHEMBL6206391 0.76 AOC3 (0.44) AOC3SLC6A4LMNAIDO1TDO2
SCHEMBL6205818 0.76 CA12 (0.52) AOC3TSHRMAPK1TDP1
SCHEMBL20960412 0.76 TDP1 (0.42) TSHRMAPK1HIF1ATDP1GAA
SCHEMBL6205146 0.76 CNR2 (0.39) AOC3SMN1; SMN2IDO1TDO2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112912081-A Substituted 2, 4-diamino-quinolines as novel agents for fibrosis, autophagy and cathepsin B (CTSB), L (CTSL) and D (CTSD) related diseases 基因科学医药公司 2021-06-04 — — CN disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 — — EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 — — WO disclosed
Send feedback